Molecular profiles and response among metastatic renal cell carcinoma patients treated with targeted therapies

被引：0
|
作者：
Donskov, F. [1 ]
Pinto, C. A. [2 ]
Predoui, R. [2 ]
Kong, F. [2 ]
Fox, C. [2 ]
Georgsen, J. [1 ]
Skaarup, K. [3 ]
Perini, R. [2 ]
Steiniche, T. [1 ]
机构：
[1] Aarhus Univ Hosp, Pathol, Aarhus, Denmark
[2] Merck & Co Inc, Clin Res, Kenilworth, NJ USA
[3] MSD Danmark, Oncol, Copenhagen, Denmark
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
155P
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [1] How to assess the response to targeted therapies in patients with metastatic renal cell carcinoma
    Shinohara, Nobuo
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (04) : 427 - 428
  • [2] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    Procopio, G.
    Verzoni, E.
    Iacovelli, R.
    Biasoni, D.
    Testa, I.
    Porcu, L.
    De Braud, F.
    [J]. BRITISH JOURNAL OF CANCER, 2012, 107 (08) : 1227 - 1232
  • [3] Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies
    G Procopio
    E Verzoni
    R Iacovelli
    D Biasoni
    I Testa
    L Porcu
    F De Braud
    [J]. British Journal of Cancer, 2012, 107 : 1227 - 1232
  • [4] Choi Response Criteria for Prediction of Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapies
    Potthast, S.
    Hess, V.
    Schmidt, N.
    Zumbrunn, T.
    Bongartz, G. M.
    Rothermundt, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S169 - S169
  • [5] Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies
    Bastin, Julie
    Werbrouck, Emilie
    Verbiest, Annelies
    Punie, Kevin
    Bechter, Oliver
    Woei-A-Jin, Feng Jung
    Wolter, Pascal
    Wildiers, Hans
    Lerut, Evelyne
    Dumez, Herlinde
    Decallonne, Brigitte
    Clement, Paul
    Vanderschueren, Dirk
    Albersen, Maarten
    Oyen, Raymond
    Schoffski, Patrick
    Beuselinck, Benoit
    [J]. ACTA CLINICA BELGICA, 2019, 74 (03) : 169 - 179
  • [6] Outcomes of patients with late relapse metastatic renal cell carcinoma treated with targeted therapies.
    Mandalapu, Kamal Kishore
    Matrana, Marc Ryan
    Poosarla, Teja
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Prognostic value of toxicities induced by targeted therapies in patients treated for a metastatic renal cell carcinoma
    Nouhaud, F. X.
    Rebibo, J. -D.
    Blanchard, F.
    Sabourin, J. -C.
    Di Fiore, F.
    Pfister, C.
    [J]. PROGRES EN UROLOGIE, 2014, 24 (09): : 563 - 571
  • [8] Economic Burden of Metastatic Clear-Cell Renal Cell Carcinoma for French Patients Treated With Targeted Therapies
    Cholley, Tiphaine
    Thiery-Vuillemin, Antoine
    Limat, Samuel
    Hugues, Marion
    Calcagno, Fabien
    Mouillet, Guillaume
    Anota, Amelie
    Nerich, Virginie
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : E227 - E234
  • [9] Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
    Antoun, Sami
    Lanoy, Emilie
    Iacovelli, Roberto
    Albiges-Sauvin, Laurence
    Loriot, Yohann
    Merad-Taoufik, Mansouriah
    Fizazi, Karim
    di Palma, Mario
    Baracos, Vickie E.
    Escudier, Bernard
    [J]. CANCER, 2013, 119 (18) : 3377 - 3384
  • [10] Incidence and severity of cardiotoxicity in metastatic renal cell carcinoma (RCC) patients treated with targeted therapies.
    Hall, Philip S.
    Witteles, Ronald
    Srinivas, Sandy
    Harshman, Lauren Christine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345